Coventry's Citizen Advice has opened its new office in Foleshill that brings back face-to-face drop-in support for the first time since the pandemic. The bureau provides residents with direct ...

Violent crime in Coventry city centre saw a substantial fall this summer according to police bosses. West Midlands Police and Crime Commissioner Simon Foster says the 10 per cent reduction ...

Wall Street analysts and state financial monitors are raising questions about the fiscal health of Coventry as its school system grapples with growing debt. Days after Moody's canceled Coventry's ...

Coventry vet practice took part in a Bury Wolf Run 14 members of Broad Lane vets took part in the event which aimed to raise money for the charity Vetlife.

Amid an ongoing pet food recall, the U.S. Food and Drug Administration (FDA) is urging pet owners not to give their dogs and cats certain food products from two different brands. Both the brands ...

Editor’s note: The FDA has issued a similar warning for some Answers brand pet food. The manufacturer, Lystn LLC, has not issued a recall, despite the Food and Drug Administration’s testing ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by Bristol-Myers Squibb (NYSE:BMY), as a novel treatment for adults with the ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the ...

26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder. Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral medication that is manufactured by Bristol Myers Squibb in New Jersey.

It is a severe, chronic mental illness that is often damaging to a person's quality of life," said Dr. Tiffany Farchione, director of psychiatry in the Office of Neuroscience in the FDA's Center ...

The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...